Restelli, Umberto, Alfredo Alberti, Adriano Lazzarin, Marzia Bonfanti, Carmela Nappi, and Davide Croce. “Budget Impact Analysis of the Use of Daclatasvir in Italy for the Treatment of Hepatitis C Virus (HCV) Genotype 3 Patients”. Farmeconomia. Health economics and therapeutic pathways 17, no. 1 (March 31, 2016): 7–12. Accessed July 23, 2025. https://provafe.seedstm.com/index.php/FE/article/view/1225.